263 related articles for article (PubMed ID: 2983024)
1. Comparison of proteins involved with cyclic AMP metabolism between synaptic membrane and postsynaptic density preparations isolated from canine cerebral cortex and cerebellum.
Aoki C; Carlin RK; Siekevitz P
J Neurochem; 1985 Mar; 44(3):966-78. PubMed ID: 2983024
[TBL] [Abstract][Full Text] [Related]
2. Properties of adenylate cyclase and cyclic nucleotide phosphodiesterase in hamster isolated capillary preparations.
Nemecek GM
Biochim Biophys Acta; 1980 Mar; 628(2):125-35. PubMed ID: 6244001
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cyclic 3',5'-nucleotide phosphodiesterase actitivty associated with synaptosomal plasma membranes and synaptic junctions.
Thérien HM; Mushynski WE
Biochim Biophys Acta; 1979 Jun; 585(2):201-9. PubMed ID: 222347
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide content and granule cell degeneration in the developing cerebellum of staggerer mice.
Spinka K; Farber DB; Lolley RN
J Neurochem; 1980 Jun; 34(6):1531-4. PubMed ID: 6103918
[No Abstract] [Full Text] [Related]
5. Cyclic nucleotides in stroke and related cerebrovascular disorders.
Palmer GC
Life Sci; 1985 May; 36(21):1995-2006. PubMed ID: 2860549
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
8. Function of a calmodulin in postsynaptic densities. III. Calmodulin-binding proteins of the postsynaptic density.
Carlin RK; Grab DJ; Siekevitz P
J Cell Biol; 1981 Jun; 89(3):449-55. PubMed ID: 6265467
[TBL] [Abstract][Full Text] [Related]
9. Function of calmodulin in postsynaptic densities. I. Presence of a calmodulin-activatable cyclic nucleotide phosphodiesterase activity.
Grab DJ; Carlin RK; Siekevitz P
J Cell Biol; 1981 Jun; 89(3):433-9. PubMed ID: 6265466
[TBL] [Abstract][Full Text] [Related]
10. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
11. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities.
Carlin RK; Grab DJ; Cohen RS; Siekevitz P
J Cell Biol; 1980 Sep; 86(3):831-45. PubMed ID: 7410481
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
14. Biochemical regulation and physiological significance of cyclic nucleotides in the nervous system.
Kebabian JW
Adv Cyclic Nucleotide Res; 1977; 8():421-508. PubMed ID: 21551
[No Abstract] [Full Text] [Related]
15. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
Davis CW; Daly JW
Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
[No Abstract] [Full Text] [Related]
16. Properties of a protein kinase C activity in synaptic plasma membrane and postsynaptic density fractions isolated from canine cerebral cortex.
Suzuki T; Siekevitz P
J Neurochem; 1989 Dec; 53(6):1751-62. PubMed ID: 2509635
[TBL] [Abstract][Full Text] [Related]
17. Distribution and properties of protein kinase and protein phosphatase activities in synaptosomal plasma membranes and synaptic junctions.
Thérien HM; Mushynski WE
Biochim Biophys Acta; 1979 Jun; 585(2):188-200. PubMed ID: 222346
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
19. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
Whalin ME; Garrett RL; Thompson WJ; Strada SJ
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
[TBL] [Abstract][Full Text] [Related]
20. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
